Clinical trialNCT04322162UnknownInterventional

Addressing Sleep Apnea Post-Stroke/TIA

SponsorVA Office of Research and DevelopmentEnrollment6Ischemic StrokeObstructive Sleep ApneaTransient Ischemic Attack (TIA)

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Effectively identifying and treating risk factors for ischemic stroke and transient ischemic attack (TIA) is important to patients, their family members, and healthcare systems. While obstructive sleep apnea (OSA) is a known risk factor for stroke and TIA that is present in more than 70% of stroke/TIA survivors, testing for OSA is infrequently performed for patients and within healthcare systems. The Addressing Sleep Apnea Post-Stroke/TIA (ASAP) study intends to improve rates of guideline-recommended OSA testing and treatment through local quality improvement initiatives (QI) conducted within and across 6 VA Medical Centers. ASAP will also determine the impact of these local QI initiatives on rates of OSA diagnosis, OSA treatment, recurrent vascular events, and hospital readmissions.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Dawn M. Bravata, MD
Richard L. Roudebush VA Medical Center, Indianapolis, IN
Principal Investigator
clinicaltrials.gov ↗
Jason Jonathon Sico, MD MHS
VA Connecticut Healthcare System West Haven Campus, West Haven, CT
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Va Connecticut Healthcare System West Haven Campus, West Haven, Ct
West Haven, Connecticut, United States
Richard L. Roudebush Va Medical Center, Indianapolis, in
Indianapolis, Indiana, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 2 Apr 2020
Primary completion: 30 Sept 2023
Completion: 31 Jul 2024
Last update posted: 12 Apr 2024
Registered enrollment: 6
Registry id: NCT04322162

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.